Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health.


Journal

Expert review of clinical pharmacology
ISSN: 1751-2441
Titre abrégé: Expert Rev Clin Pharmacol
Pays: England
ID NLM: 101278296

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 10 4 2019
medline: 17 5 2019
entrez: 10 4 2019
Statut: ppublish

Résumé

The potentials of Africa for growth and economic transformation through science remains challenging because of existing gaps in knowledge and infrastructure. The Africa Pharmacological Science Gateway project and the Medicines Utilization Research in Africa Group seek to meet the research needs of African pharmacologists. This study aimed at identifying priority needs that might be met by access to information and tools through e-infrastructure. A web-based cross-sectional study among 472 members of pharmacological societies in Africa to obtain information on their research interests and skills, available resources, needs, and knowledge gaps. Descriptive analyses were done. A total of 118 responses from 13 countries were received, mostly from Nigeria (48.3%) and South Africa (21.3%). Respondents had wide ranges of research interests predominantly in drug utilization research. The desired resources included drug utilization research training and tools, pharmacokinetics and pharmacometrics modeling training and tools, drug-drug interaction and medicine prices resources, statistical analysis resources, access to journals, training in specific laboratory techniques, equipment and funding for research-related activities. Key areas of needs not currently provided by the African Pharmacological Science Gateway e-infrastructure were identified to guide the further provision of resources on the e-infrastructure and potentially enhance research capacity within the continent.

Identifiants

pubmed: 30961406
doi: 10.1080/17512433.2019.1605903
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-489

Auteurs

Olayinka O Ogunleye (OO)

a Department of Pharmacology, Therapeutics and Toxicology , Lagos State University College of Medicine , Lagos , Nigeria.
b Department of Medicine , Lagos State University Teaching Hospital , Lagos , Nigeria.

Joseph O Fadare (JO)

c Department of Pharmacology and Therapeutics , College of Medicine, Ekiti State University , Ado-Ekiti , Nigeria.

Jaran Eriksen (J)

d Division of Clinical Pharmacology, Department of Laboratory Medicine , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.
e Department of Public Health Sciences , Karolinska Institutet , Stockholm , Sweden.

Omo Oaiya (O)

f West and Central Africa Research and Education Network , Accra , Ghana.

Amos Massele (A)

g Department of Biomedical Sciences, Faculty of Medicine , University of Botswana , Gaborone , Botswana.

Ilse Truter (I)

h Drug Utilization Research Unit (DURU), Department of Pharmacy , Nelson Mandela Metropolitan University , Port Elizabeth , South Africa.

Simon J E Taylor (SJE)

i Department of Computer Science , Brunel University , London , U.K.

Brian Godman (B)

d Division of Clinical Pharmacology, Department of Laboratory Medicine , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.
j Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , U.K .
k Department of Health Economics , Liverpool Management School, Liverpool University , Liverpool , U.K .
l School of Pharmacy , Sefako Makgatho Health Sciences University , Pretoria , South Africa.

Lars L Gustafsson (LL)

d Division of Clinical Pharmacology, Department of Laboratory Medicine , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH